Question 16

Methotrexate is indicated to treat rheumatoid arthritis.

Methotrexate is primarily used as a treatment for rheumatoid arthritis, where it helps to reduce inflammation and slow disease progression.

A) rheumatoid arthritis.

This option is correct. Methotrexate is a disease-modifying antirheumatic drug (DMARD) that effectively alleviates symptoms and prevents joint damage in patients with rheumatoid arthritis.

B) heart failure.

This option is incorrect. Methotrexate is not indicated for the treatment of heart failure, as it does not address the underlying cardiac issues or improve heart function.

C) type 1 diabetes.

This option is incorrect. Methotrexate is not used in the management of type 1 diabetes, which requires insulin therapy and does not benefit from the immunosuppressive effects of methotrexate.

D) kidney stones.

This option is incorrect. Methotrexate does not have any role in treating kidney stones, which are typically managed through hydration, dietary changes, or surgical intervention if necessary.

Conclusion

Methotrexate is definitively indicated for the treatment of rheumatoid arthritis due to its ability to modify disease activity and improve patient outcomes. In contrast, the other options do not align with the therapeutic uses of methotrexate, highlighting its specific application in autoimmune conditions rather than other unrelated medical issues.